Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

This study hypothesizes that approximately 50% of rectal cancer patients can preserve their rectum using a watch-and-wait strategy if they achieve a complete or near-complete clinical response to total neoadjuvant therapy (TNT). The objective is to determine whether the complications, quality of life, and survival rates of rectal cancer patients who have achieved a complete or near-complete clinical response to TNT, followed by a watch-and-wait approach, are comparable to those of patients who undergo surgery first. Additionally, the study aims to identify potential prognostic and predictive m

Trial Details

NCT ID
NCT06758830
Phase
PHASE2 / PHASE3
Sponsor
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos
Status
RECRUITING
Cancer Type
Colon Cancer Colorectal Cancer
Interventions
  • Radiation Therapy
  • Chemoradiotherapy
  • Consolidation Chemotherapy
  • Surgery
  • Part two
  • Adjuvant treatment
Locations (sample)
  • Vilnius, Lithuania|54.68916,25.2798

Key Eligibility Criteria

  • Over 18 years of age.
  • Participants who agreed to participate in the study signed an informed consent form.
  • The Eastern Cooperative Oncology Group (ECOG) score ranges from 0 to 2.
  • Pathologically confirmed rectal adenocarcinoma.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colon Cancer Colorectal Cancer Trials on Trialify →